Please login to the form below
Emergent BioSolutions
This page shows the latest Emergent BioSolutions news and features for those working in and with pharma, biotech and healthcare.
Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine
Follows initial deal agreed in June. US-based CDMO Emergent BioSolutions has agreed a deal with AstraZeneca to expand manufacturing of the latter's potential COVID-19 vaccine. ... According to Emergent, the deal is valued at approximately $174m and runs
Latest news
-
Shake-up at GSK could claim antibiotics unit and UK facilities
In the meantime the company has also announced a product divestment - selling its anthrax prevention drug raxibacumab to Emergent BioSolutions for around $96m. ... The FDA-approved therapy is tied to a $130m supply deal with the US government, which will
-
GSK: We had a social responsibility to work on Ebola
More recently it was revealed this week that will be working with Emergent BioSolutions on a phase I trial that would addd that firm's Ebola vaccine candidate as a booster
-
TB vaccine disappoints, but others in the pipeline
Helen McShane of the University of Oxford in the UK. The trial was sponsored by non-profit vaccines company Aeras, the Wellcome Trust and the Oxford-Emergent Tuberculosis Consortium (OETC), a ... joint venture between the University of Oxford and
-
Biologics buoyant
Phase I . 28. Oxford Biomedica/Emergent BioSolutions. Prime boost technology - vaccines.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Deal Watch table for August 2014
187. Emergent BioSolutions/ Morphosys. Licence, joint development &commercialisation. MOR209/ES414, anti-PSMA/anti-CD3 bi-specific antibody targeting prostate cancer (preclinical).
-
Deal Watch table for April 2013
60. Bracco Diagnostics/ Emergent BioSolutions. Asset purchase. Healthcare Protective Products Division.
-
Interview: Charles Mgone, EDCTP
But it doesn't stop the contagious form acquired by adults. So we are working with Emergent BioSolutions and Aeras, a non-profit product developer, as well as institutions in the
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Barry Labinger joins Biothera Pharmaceutical
Labinger has nearly three decades of pharmaceutical and biotech industry experience, with roles at Emergent BioSolutions, Human Genome Sciences, 3M Pharmaceuticals and Immunex. ... Labinger most recently served as executive vice president and president,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
- Nucleus Global announces a trio of promotions
- UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
